Avoid live vaccines
Avoid live vaccines during treatment if contraindicated.
Leaflet TERIFLUNOMIDA TEVA 14mg film-coated tablets
- Product code:
- W71663001
- Quantity:
- 14
- Indicated for:
- multiple sclerosis
- Route of administration:
- oral
- Substance:
- teriflunomide (immunomodulator)
- ATC
- L04AK02 — Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Dihydroorotate dehydrogenase (DHODH) inhibitors
Precautions:
Immunosuppression / infection risk
This medicine may increase the risk of infections.
Breastfeeding warning
Use during breastfeeding only on medical advice.
Pregnancy warning
Use during pregnancy only on medical advice.
Teriflunomide is an immunomodulatory medication used for the treatment of relapsing multiple sclerosis. It works by inhibiting de novo pyrimidine synthesis, thereby reducing the activity of immune cells involved in the inflammatory process.
The medication is taken orally, usually once daily, as directed by a doctor. It is important for patients to follow the prescribed dosage and undergo regular medical check-ups to monitor liver and hematological function.
Patients should be aware of potential side effects, such as nausea, diarrhea, or elevated liver enzymes. It is important to inform the doctor of any unusual symptoms or the use of other medications.
Common side effects include nausea, diarrhea, hair loss, and elevated liver enzymes. In rare cases, severe reactions such as hepatotoxicity or allergic reactions may occur. Patients should be informed of these risks before starting treatment.
The medication is taken orally, usually once daily, as directed by a doctor. It is important for patients to follow the prescribed dosage and undergo regular medical check-ups to monitor liver and hematological function.
Patients should be aware of potential side effects, such as nausea, diarrhea, or elevated liver enzymes. It is important to inform the doctor of any unusual symptoms or the use of other medications.
Common side effects include nausea, diarrhea, hair loss, and elevated liver enzymes. In rare cases, severe reactions such as hepatotoxicity or allergic reactions may occur. Patients should be informed of these risks before starting treatment.
General data about TERIFLUNOMIDA TEVA 14mg
- Substance:
- teriflunomide
- Date of latest medicines list:
- 01-03-2026
- Product code:
- W71663001
- Concentration:
- 14mg
- Pharmaceutical form:
- film-coated tablets
- Quantity:
- 14
- Product type:
- Generic medicine
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Concentrations available for teriflunomide
- 14mg
- 7mg